Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2377
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers ; volume:13 ; number:1 ; day:11 ; month:7 ; year:2013 ; pages:1-4 ; date:12.2013
BMC neurology ; 13, Heft 1 (11.7.2013), 1-4, 12.2013

Urheber
Muñoz, Delicias
Beteiligte Personen und Organisationen
Escartín, Antonio
Dapena, Dolores
Coret, Francisco
Fernández-Uría, Dionisio
Pérez, Domingo
Casanova, Bonaventura
Guijarro-Castro, Cristina
Munteis, Elvira
del-Campo Amigo, María
Pego, Robustiano
Calles, Carmen
García-Rey, César
Monsalve, Nuria
Sánchez-Matienzo, David
SpringerLink (Online service)

DOI
10.1186/1471-2377-13-82
URN
urn:nbn:de:1111-2016030331472
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:30 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Muñoz, Delicias
  • Escartín, Antonio
  • Dapena, Dolores
  • Coret, Francisco
  • Fernández-Uría, Dionisio
  • Pérez, Domingo
  • Casanova, Bonaventura
  • Guijarro-Castro, Cristina
  • Munteis, Elvira
  • del-Campo Amigo, María
  • Pego, Robustiano
  • Calles, Carmen
  • García-Rey, César
  • Monsalve, Nuria
  • Sánchez-Matienzo, David
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Relapsing/remitting type 1 diabetes

Relapsing/remitting type 1 diabetes

Postural Control in Relapsing-Remitting Multiple Sclerosis

Postural Control in Relapsing-Remitting Multiple Sclerosis

Endocarditis following ocrelizumab in relapsing-remitting MS

Endocarditis following ocrelizumab in relapsing-remitting MS

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Serum prolactin in patients with relapsing remitting multiple sclerosis

Serum prolactin in patients with relapsing remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis

Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis

Verbundene Objekte